News & Blog

FierceBiotech: From ‘science fiction to reality’: New George Church-founded biotech raises $75M for cell therapy platform

STAT: A new cell therapy company takes its vision from four founders, and its skin from George Church

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy

MEC in Q2 2024

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting

Truvian featured in the WSJ: The Companies Realizing Theranos’s Failed Dream

Aspen Neuroscience: Study of ANPD001 Autologous Neuronal Cell Replacement Treatment Approach Published in Journal of Neurosurgery

Truvian Health raises $74M to bring blood testing to anyone, anywhere

SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment

ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association